Analyst Ratings for Oncternal Therapeutics (ONCT) [Buys]

ONCT Rating Summary

ONCT Price Target Summary

* Over Last 12-Mos
  |   Expand Research on ONCT
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $15.25 (+154.6%) * Over Last 12-Mos
Rating Score: 10 / 10   Percentile Rank: 95%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
4/7/2021 Oppenheimer
» Updated 4/16/2021
Hartaj Singh New Coverage Outperform
(N/A)
16.00
(14.00)
8.25
(5.99)
-27.39% Details
3/30/2021 Brookline Capital Markets N/A New Coverage Buy
(N/A)
16.00
(N/A)
7.58
(5.99)
-20.98% Details
Like ONCT Ratings? Also take a look at CBAY, GNMK, MIST, DRTX

ONCT Ratings News